These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27377845)

  • 1. Methotrexate treatment in progressive tubal ectopic pregnancies and hCG-related clinicosurgical implications.
    Dogan A; Gulhan I; Uyar I; Ekin A; Gezer C; Bilgin M; Taner CE; Ertas IE
    Kaohsiung J Med Sci; 2016 Jun; 32(6):317-22. PubMed ID: 27377845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin.
    Cohen A; Bibi G; Almog B; Tsafrir Z; Levin I
    Fertil Steril; 2014 Dec; 102(6):1646-9. PubMed ID: 25241368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
    Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
    Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
    Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
    Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies.
    Girija S; Manjunath AP; Salahudin A; Jeyaseelan L; Gowri V; Abu-Heija A; Al Kharusi L
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():230-233. PubMed ID: 28683376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate.
    da Costa Soares R; Elito J; Camano L
    Arch Gynecol Obstet; 2008 Oct; 278(4):319-24. PubMed ID: 18274766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
    Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
    Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
    Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
    Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of methotrexate treatment failure in ectopic pregnancy.
    Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
    J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day 1 change in maternal serum β-HCG levels as an early predictor of successful medical therapy in ectopic pregnancies.
    Ahmed MR; Sayed Ahmed WA; Mohamed TY
    J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2403-2407. PubMed ID: 30608010
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the parameters in predicting single-dose methotrexate therapy success for ectopic pregnancy.
    Deniz S; Ali B; Canan U; Yılmaz AH; Olcay I; Burcu D; Fatma GK
    J Obstet Gynaecol Res; 2024 May; 50(5):856-863. PubMed ID: 38476034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.
    Dai Y; Zhang G; Zhu L; Lang J; Liu Z
    J Minim Invasive Gynecol; 2017; 24(7):1195-1199. PubMed ID: 28800968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
    Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
    Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
    Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Additional Dose Requirement be Determined before the Seventh Day to Successfully Treat Tubal Ectopic Pregnancy with a Single-dose Methotrexate Protocol?
    Akselim B; Karaşin SS; Sabır YA
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1046-1050. PubMed ID: 34500519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
    Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
    Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
    Yıldız A; Bilge O
    Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?
    Kucera E; Schindl M; Klem I; Sam C; Hanzal E; Kölbl H; Leodolter S; Sliutz G
    Gynecol Obstet Invest; 2000; 49(1):6-11. PubMed ID: 10629365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.